|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PARRIS N. GLENDENING, Governor
|
|
|
|
|
|
Ch. 17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) THE DEPARTMENT MAY:
(I) CONDUCT THE BASELINE CANCER STUDY OR ANY PART OF THE
STUDY: OR
(II) CONTRACT WITH A HIGHER EDUCATION INSTITUTION OR
PRIVATE ENTITY TO CONDUCT THE BASELINE CANCER STUDY OR ANY PART OF THE
STUDY.
(D) THE BASELINE CANCER STUDY SHALL MEASURE:
(1) THE NUMBER AND PERCENTAGE OF INDIVIDUALS WHO HAVE EACH
TARGETED CANCER BOTH STATEWIDE AND IN EACH COUNTY;
(2) THE NUMBER AND PERCENTAGE OF INDIVIDUALS WITHIN EACH
MINORITY POPULATION WHO HAVE EACH TARGETED CANCER BOTH STATEWIDE
AND IN EACH COUNTY:
(3) THE MORTALITY RATE FOR EACH TARGETED CANCER BOTH
STATEWIDE AND IN EACH COUNTY;
(4) THE MORTALITY RATE FOR DIFFERENT MINORITY POPULATIONS
FOR EACH TARGETED CANCER BOTH STATEWIDE AND IN EACH COUNTY;
(5) THE NUMBER OF IDENTIFIABLE CANCERS WITH A HIGH INCIDENCE
IN THE STATE FOR WHICH THERE ARE EFFECTIVE METHODS OF:
(I) EARLY DETECTION; AND
(II) PREVENTION AND TREATMENT AFTER DETECTION;
(6) ANY ASPECT OF TARGETED AND NON-TARGETED CANCERS THAT
THE DEPARTMENT SEEKS TO MEASURE; AND
(7) ANY OTHER FACTOR THAT THE DEPARTMENT DETERMINES TO BE
IMPORTANT FOR MEASURING RATES OF CANCERS IN THE STATE OR FOR
EVALUATING WHETHER THE PROGRAM MEETS ITS OBJECTIVES.
(E) IN ORDER TO MAXIMIZE THE COST EFFECTIVENESS OF THE BASELINE
CANCER STUDY, THE DEPARTMENT MAY USE DATA IN THE MARYLAND CANCER
REGISTRY OR PROVIDED BY OTHER SOURCES, TO THE EXTENT THAT THESE
SOURCES PROVIDE RELIABLE DATA RELATING TO THE FACTORS LISTED IN
SUBSECTION (D) OF THIS SECTION.
(F) (1) IF THE DEPARTMENT CHOOSES TO HAVE A HIGHER EDUCATION
INSTITUTION OR PRIVATE ENTITY CONDUCT THE BASELINE CANCER STUDY OR ANY
PART OF THE STUDY, THE DEPARTMENT SHALL ISSUE A REQUEST FOR PROPOSAL TO
SELECT THE ENTITY THAT WILL CONDUCT THE STUDY OR THE RELEVANT PART OF
THE STUDY.
(2) THE REQUEST FOR PROPOSAL SHALL REQUIRE THAT ANY
METHODOLOGY OR MODEL THAT IS USED BY THE ENTITY TO CONDUCT THE
BASELINE CANCER STUDY OR THE RELEVANT PART OF THE STUDY, ANY DATA
|
|
|
|
|
|
|
|
|
|
- 265 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
